Medical Device News Magazine

Volta Labs and Watchmaker Genomics Partner to Simplify and Optimize NGS Library Prep

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...


Volta Labs, a genomics applications company, and Watchmaker Genomics, a supplier of innovative products for molecular analysis, partner to leverage their technologies to power Volta’s short-read library prep kits.


Volta Labs and Watchmaker Genomics are jointly committed to making efficient, accessible, and cost-effective library prep a reality. With the launch of Volta’s Callisto™ Sample Prep System, Watchmaker Genomics will provide the reagents behind various VoltaPrep™ library prep kits.

Trey Foskett, CEO of Watchmaker Genomics

“Volta’s digital fluidics technology and their approach to building automated sample prep applications are impressive. Watchmaker has a passion for delivering superior data quality with simple and automatable workflows. Combining Volta’s cutting-edge technology with our innovative reagents delivers in both of these areas, and we look forward to a continued partnership.”

Udayan Umapathi, CEO at Volta Labs

“Watchmaker has set the bar high for enzyme engineering and library prep workflow development. We are energized to work with their talented team to address quality, cost, and scalability challenges that currently exist in sample prep. This collaboration is the first in a series of Volta applications that will be powered by Watchmaker chemistry.”

Callisto™ Sample Prep System

The Callisto™ Sample Prep System offers programmable, precise, and plastic-free liquid manipulation with pre-optimized applications to support short- and long-read sequencing workflows. With a growing menu of library prep kits powered by Watchmaker Genomics’ solutions, Volta will continue to expand the universe of pre-optimized applications available through Callisto and enable labs to maximize advancements in sequencing.

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

ArisGlobal Reports | Newest Version of LifeSphere® Regulatory Platform Launches

Ann-Marie Orange, CIO & Global Head of R&D shares, “With more than 35 years of experience in life sciences technology, ArisGlobal is the only technology company offering strong Safety, Regulatory, and Quality Management solutions powered with next-generation cognitive computing, delivering unmatched interoperability across the R&D IT ecosystem. Over the last 18 months ArisGlobal has made significant investment in the strategic acquisitions of Amplexor Life Sciences and SPORIFY, along with technology R&D – and we’re not stopping.”